Emergent Biosolutions
EBS • NYSE • Stock Fundamentals
Emergent Biosolutions is a drug manufacturers - specialty & generic company in the healthcare sector trading on NYSE, led by CEO Joseph C. Papa Jr., with a market cap of $432.9M.
Market Cap$432.9M
Employees1.6K
CEOJoseph C. Papa Jr.
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Emergent Biosolutions FAQ
Common questions about Emergent Biosolutions
Emergent Biosolutions (EBS) has a market capitalization of $432.9M and trades on NYSE.
Emergent Biosolutions has approximately 1,600 employees.